Depressive Disorder  >>  GSK356278  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK356278 / GSK
NCT01031186: First Time in Human Study

Completed
1
20
RoW
GSK356278, PLACEBO
GlaxoSmithKline
Depressive Disorder and Anxiety Disorders
04/10
04/10

Download Options